These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 8194951

  • 1. MMR immunisation status among Dublin paediatric A&E attenders.
    Murphy AW, Power R, Kinlen DM, Johnson Z.
    Ir Med J; 1994; 87(2):40-2. PubMed ID: 8194951
    [Abstract] [Full Text] [Related]

  • 2. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M, Pattison HM.
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [Abstract] [Full Text] [Related]

  • 3. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 4. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 5. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R, Svensson E, Trollfors B, Borres MP.
    Acta Paediatr; 2004 Sep 25; 93(9):1232-7. PubMed ID: 15384890
    [Abstract] [Full Text] [Related]

  • 6. MMR immunisation coverage in Christchurch. Christchurch Immunisation Coordination Committee.
    Ford RP, Bell DW, Slade B, McCormack SP.
    N Z Med J; 1998 Aug 14; 111(1071):301. PubMed ID: 9760956
    [Abstract] [Full Text] [Related]

  • 7. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W.
    Przegl Epidemiol; 1993 Aug 14; 47(1-2):47-53. PubMed ID: 8351387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 Aug 14; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 10. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM, Saunders EF, Petric M, Gold R.
    Bone Marrow Transplant; 1996 Apr 14; 17(4):633-6. PubMed ID: 8722367
    [Abstract] [Full Text] [Related]

  • 11. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks.
    Clark A, Marshall R.
    Commun Dis Public Health; 1999 Jan 14; 2(1):50-3. PubMed ID: 10462897
    [Abstract] [Full Text] [Related]

  • 12. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S.
    Bone Marrow Transplant; 2004 Jun 14; 33(12):1187-90. PubMed ID: 15077129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 14; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 16. Illness after measles-mumps-rubella vaccination.
    Freeman TR, Stewart MA, Turner L.
    CMAJ; 1993 Dec 01; 149(11):1669-74. PubMed ID: 8242506
    [Abstract] [Full Text] [Related]

  • 17. Lone parent families are an independent risk factor for lower rates of childhood immunisation in London.
    Sharland M, Atkinson P, Maguire H, Begg N.
    Commun Dis Rep CDR Rev; 1997 Oct 17; 7(11):R169-72. PubMed ID: 9350095
    [Abstract] [Full Text] [Related]

  • 18. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
    Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA.
    Clin Immunol; 2005 May 17; 115(2):154-61. PubMed ID: 15885638
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parents' perspectives on the MMR immunisation: a focus group study.
    Evans M, Stoddart H, Condon L, Freeman E, Grizzell M, Mullen R.
    Br J Gen Pract; 2001 Nov 17; 51(472):904-10. PubMed ID: 11761204
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.